Skip to content

Ultrasound for Detection of Prostate Cancer

Dual-frequency Ultrasound for Detection of Prostate Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05736094
Acronym
SURF
Enrollment
11
Registered
2023-02-21
Start date
2023-02-14
Completion date
2024-03-31
Last updated
2024-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.

Detailed description

Prospectively recruited patients before prostatectomy and/or definitive radiotherapy will be included in the study. Dual-frequency ultrasound imaging will be compared to standard transrectal ultrasound and MRI. Imaging of primary tumor with dual-frequency ultrasound technology including the use of microbubble contrast-media. A prostate biopsy and blood sample will be taken from each patient, for histopathology and explorative biomarkers.

Interventions

DEVICESURF

Dual-frequency ultrasound

Sponsors

Norwegian University of Science and Technology
CollaboratorOTHER
University of Oslo
CollaboratorOTHER
The Research Council of Norway
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years onwards * Signed written informed consent to perform rectal and transperineal ultrasound

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frameDescription
Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.1 daySensitivity and specificity outcome measures

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026